Imaging plays an essential role in addressing hepatic steatosis. Yet, radiologists have had almost zero involvement in shaping medical knowledge about the disease. 

ACR, the Society of Interventional Radiology and others recently submitted a letter to 5 of the 7 contractors, expressing concern about trigger-point injections. 

The U.S. Food and Drug Administration has its hands full making sure medical AI products are safe, efficacious and trustworthy before they hit the market. The rise of ever-more-innovative iterations of the technology—not least generative AI—is only adding to the burden. 

The Texas Hospital Association said answering the question, which stems from an executive order from Gov. Greg Abbot, will not impact patient care.

Device-based therapies can provide considerable value for heart failure patients when used alongside traditional pharmaceutical treatments. A new HFSA scientific statement outlines the benefits of these devices, urging care teams to implement them into daily practice.